Hepatocellular Carcinoma — Trials

Hepatocellular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

3,123 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 693
Recruiting: 411
Ph III recruiting: 39
Growth YoY: +0.6%
Industry share: 23%
Top sponsor: Sun Yat-sen University
Termination share: 34.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (356)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06084234	National Liver Cancer Screening Trial(TRACER)	recruiting	Phase 4	5,500	University of Texas Southwestern Medical CenterOTHER	1	Sep 25, 2026	clinicaltrials
NCT07059494	Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant	recruiting	Phase 4	40	Icahn School of Medicine at Mount SinaiOTHER	1	Jul 28, 2026